GLP-1s are not going anywhere pharma manufacturers continue to evolve their GLP-1/GIP product offerings (e.g., Eli Lillys Zepbound is the newest on the market), and the number of addressable indications is increasing (e.g., recent clinical evidence that may merit further FDA approval of GLP-1s for cardio-metabolic, nephrological and neurological indications)
Ozempic is approved to treat type 2 diabetes
Administration of the QV formulation increased the pancreatic GLP-1R level, indicating a possible increase in the availability of GLP-1, whereas in the liver these levels did not change
A The authors note that coffee enemas have been responsible for three deaths, two resulting from electrolyte imbalance and the other from sepsis
Tirazeptide : Using this medicine while you are pregnant can harm your unborn baby
As with any administered injectable or drugs, there are concerns about whether you require a prescription and whether the OHIP covers it